Literature DB >> 25436490

Ocular surface squamous neoplasia: evidence for topical chemotherapy.

Jacob Pe'er.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25436490     DOI： 10.1097/IIO.0000000000000050

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  4 in total

1.  Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus).

Authors:  Preethi S Ganapathy; Thomas Plesec; Arun D Singh
Journal:  Am J Ophthalmol Case Rep       Date:  2017-02-03

Review 2.  Update on pharmacotherapy for ocular surface squamous neoplasia.

Authors:  Ghada Al Bayyat; Dan Arreaza-Kaufman; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-12

3.  Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Reza Ghaffari; Sahar Barijani; Arash Alivand; Golshan Latifi; Hamed Ghassemi; Mehran Zarei-Ghanavati; Ali R Djalilian
Journal:  J Curr Ophthalmol       Date:  2021-10-22

4.  Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.

Authors:  Raffaele Parrozzani; Luisa Frizziero; Sara Trainiti; Ilaria Testi; Giacomo Miglionico; Elisabetta Pilotto; Stella Blandamura; Ambrogio Fassina; Edoardo Midena
Journal:  Br J Ophthalmol       Date:  2016-12-09       Impact factor: 4.638
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.